By Sheeba M. | April 30, 2026
Global Cannabis Expansion: Mexico, Germany, and Australia Racing for Market Share
If you’re tracking cannabis stocks and only looking at U.S. operators, you’re missing the real inflection point. Global cannabis legalization is accelerating faster than anyone predicted. Four countries moved major policy changes in the last 60 days. This is a wave, not a ripple.
Mexico: The Dark Horse Market
Mexico’s recreational legalization (finalized April 2026) opens a $4.2B addressable market immediately. Unlike Canada’s competitive race, Mexico’s regulatory framework favors consolidation. Major producers with existing Latin American footprints are positioning aggressively.
Greengro/Greenrose (GTBIF) already has cultivation operations in Colombia and Panama. Mexico entry requires new licenses, but capital and expertise are already deployed. Estimated 12-18 month path to first revenue recognition. Market timing: Q3 2026 is when initial export flows should appear in financials.
Germany’s Pharmacy Play
Germany legalized medical cannabis in 2021, but distribution has been bottlenecked by pharmacy scarcity and import delays. New framework (effective May 2026) opens pharmacy distribution channels. CBD products in German pharmacies could see 200% volume growth by end of 2026.
This benefits Canadian large-cap producers more directly, but U.S. hemp-derived CBD companies like ZASH are exploring European export pathways.
Australia’s Import Authorization
Australia approved medical cannabis imports from licensed producers (March 2026), but domestic cultivation licensing just opened in April. First harvests won’t arrive until Q2 2027, so this is a longer-term play. However, companies securing licenses now will control premium pricing for 2-3 years before competition densifies.
The Valuation Arbitrage
U.S. MSOs are priced on domestic revenue multiples (5-7x sales). International platforms like GTBIF are trading on speculation and early revenue, often at 0.8-2x sales because investors underweight international optionality. Smart money is accumulating exposure before Mexico and Germany revenues hit the 10-Q.
Sources
- Mexico Government (Gob.mx) — Cannabis legalization framework
- Bundestag — Germany medical cannabis policy updates
- Australian TGA — Therapeutic Goods Administration cannabis guidance
Track cannabis stocks with the Weedstock Real-Time Tracker